To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Phone: 517-913-3890
Karmanos Cancer Institute at McLaren Greater Lansing is the leader in cancer care, treatment, diagnostics, education, clinical trials and research. Karmanos is your best chance in the fight against cancer.
Oncology - Radiation
Oncology - Hematology
Oncology - Hematology, Physician Assistant
Internal Medicine, Oncology - Hematology, Oncology - Medical
Oncology - Hematology, Oncology - Medical
Genetics
John Lacks
Karmanos Cancer Institute
Gene Hodulik
Arthur Roat
The Barbara Ann Karmanos Cancer Institute is pleased to announce the winners of its 2021 Heroes of Cancer Awards. This year's event celebrates Kar...
The Barbara Ann Karmanos Cancer Institute is pleased to announce that it has entered into a partnership with The Toledo Clinic to establish a new ...
Doctors have long known that the Human Papilloma Virus (HPV) is linked to cervical cancer. However, many members of the general public and even me...
With everything going on in the world it may be hard to establish healthy sleep habits, but it’s more important than ever to make sure you are pra...
Lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States, according to the...